Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study
article
OA: closed
CC0
⤵ 191 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This 12-week, randomized, double-blind, placebo-controlled study investigated the efficacy of dienogest in treating endometriosis-associated pelvic pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
- Diagnosis and management of endometriosis. via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile via openalex
- Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex
- High-dose pilot study with the novel progestogen dienogestin patients with endometriosis via openalex
- Lipid Metabolism During Treatment of Endometriosis with the Progestin Dienogest via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Progestagens and anti-progestagens for pain associated with endometriosis via openalex
- Progestogens for endometriosis: forward to the past via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience via openalex
- Update on Endometriosis via openalex
- W6681100027 via openalex
- W1979285610 via openalex
- W2022685057 via openalex
- W2080251208 via openalex
- W2081376262 via openalex
- W2096980318 via openalex
- W2101417341 via openalex
- W2133744133 via openalex
- W4254444804 via openalex
- W6608139517 via openalex
Cited by (50)
- Integrative single-cell analysis reveals Bu-Shen-Huo-Xue Formula rescues iron-overloaded ovarian function via rewiring IFN-γ/JAK/STAT/CXCL10-driven immune-stromal interactions and BNIP3-mediated mitophagy in endometriosis 2026
- Short-term safety of dienogest on bone mineral density in Iranian women with endometriosis: A cross-sectional study 2026
- Effects of dienogest treatment on endometrioma-related clinical symptoms and endometrioma size: retrospective cohort study 2025
- Progestagens for pain symptoms associated with endometriosis 2025
- Deeply Infiltrating Endometriosis (DIE) No More: Dienogest as a Game Changer in Rectovaginal Endometriosis 2025
- The efficacy of progestins in managing pain associated with endometriosis, fibroids and pre-menstrual syndrome: a systematic review 2025
- Hormonal Treatment of Endometriosis: A Narrative Review 2025
- High inhibition ratio and transformation index of 2 mg dienogest: further evidence for its use in endometriosis treatment 2025
- Endometriose 2024
- Dienogest treatment in women with endometriosis: A retrospective cohort study in Taiwan 2024
- Long-term therapy with dienogest or other oral cyclic estrogen-progestogen can reduce the need for ovarian endometrioma surgery 2024
- A systematic review and Bayesian analysis of the adverse effects of dienogest 2024
- The effect of dienogest treatment on anti-Mullerian hormone in patients with endometrioma: a 12-month follow-up study 2024
- A systematic literature review on patient-reported outcome domains and measures in nonsurgical efficacy trials related to chronic pain associated with endometriosis: an urgent call to action 2024
- Safety and efficacy of pharmacotherapies for pelvic inflammatory disease and endometriosis 2024
- Levonorgestrel intrauterine system versus dienogest effect on quality of life of women with deep endometriosis: a randomized open-label clinical trial 2024
- Substituting a randomised placebo control group with a historical placebo control in an endometriosis pain trial: a case study re-evaluating trial data using historical control data from another trial 2023
- Evaluation of long-term efficacy and safety of dienogest in patients with chronic cyclic pelvic pain associated with endometriosis 2023
- A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment 2023
- Clinical and sonographic impact of oral contraception in patients with deep endometriosis and adenomyosis at 2 years of follow-up 2023
- Impact of Dienogest Alone or in Combination with Ethinylestradiol on the Quality of Life of Women with Endometriosis: A Prospective Cohort Study 2023
- Aktuelle Aspekte der endokrinen Therapie der Endometriose und der Adenomyose 2023
- Endometriose 2023
- Medikamentöse Therapie der Endometriose – ein Update 2023
- ENDOMETRİOZ 2023
- Efficacy and Safety of Dienogest in the Management of Women with Endometriosis; Systematic Review and Meta-Analysis 2023
- Dienogest (Monopräparat) 2022
- A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms 2022
- Clinical practice guidelines for endometriosis in Japan (The 3rd edition) 2022
- Dienogest May Reduce Estradiol- and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture- and Mouse Model-Based Study 2022
- The dienogest-related cystitis in women with endometriosis: a prospective, controlled, comparative study 2022
- Impact of Long-Term Dienogest Therapy on Quality of Life in Asian Women with Endometriosis: the Prospective Non-Interventional Study ENVISIOeN 2022
- Medikamentöse Therapie der Endometriose – ein Update 2022
- Hormonal Therapy in Endometriosis and Adenomyosis: Progestins 2022
- Progesterone receptor ligands for the treatment of endometriosis 2022
- The issues of endometriosis hormonal treatment in reproductive age women 2022
- Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis 2021
- Gestagenes in the treatment of endometriosis: efficiency, safety, bioequivalence, transferability 2021
- Dienogest reduces endometrioma volume and endometriosis-related pain symptoms 2021
- Endometriosis - Recent Advances, New Perspectives and Treatments 2021
- Efficacy and safety of Elagolix in the treatment of endometriosis associated pain: a systematic review and network meta-analysis 2021
- Role of medical treatment of endometriosis 2021
- Endometriosis. Case report 2021
- Medical management of endometriosis 2021
- Assessment of Quality of Life, Sexual Quality of Life, and Pain Symptoms in Deep Infiltrating Endometriosis Patients with or Without Associated Adenomyosis and the Influence of a Flexible Extended Combined Oral Contraceptive Regimen: Results of a Prospective, Observational Study 2021
- Progestogens and Endometriosis 2021
- Potential Therapeutic Options and Perspectives for Alleviation of Endometrial Estrogen Dominance and Progesterone Resistance in Endometriosis 2021
- Efficacy of dienogest vs combined oral contraceptive on pain associated with endometriosis: Randomized clinical trial 2021
- Short-term Efficacy of Dienogest in Improving Pain in Patients with Endometriosis: A Single-center Experience 2021
- Medical and surgical interventions to improve the quality of life for endometriosis patients: a systematic review 2021
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:12.951333+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK